185 related articles for article (PubMed ID: 17491551)
21. [Retinoids: mechanisms of action].
Berbis P
Ann Dermatol Venereol; 2010 Nov; 137 Suppl 3():S97-103. PubMed ID: 21185985
[TBL] [Abstract][Full Text] [Related]
22. Rexinoid-induced expression of IGFBP-6 requires RARbeta-dependent permissive cooperation of retinoid receptors and AP-1.
Uray IP; Shen Q; Seo HS; Kim H; Lamph WW; Bissonnette RP; Brown PH
J Biol Chem; 2009 Jan; 284(1):345-353. PubMed ID: 18957410
[TBL] [Abstract][Full Text] [Related]
23. Keratinocyte-specific retinoid regulation of human cellular retinoic acid binding protein-II (hCRABPII) gene promoter requires an evolutionarily conserved DR1 retinoic acid-responsive element.
Di W; Li XY; Datta S; Aström A; Fisher GJ; Chambon P; Voorhees JJ; Xiao JH
J Invest Dermatol; 1998 Dec; 111(6):1109-15. PubMed ID: 9856825
[TBL] [Abstract][Full Text] [Related]
24. Linkage between retinoid and fatty acid receptors: implications for breast cancer prevention.
Stoll BA
Eur J Cancer Prev; 2002 Aug; 11(4):319-25. PubMed ID: 12195157
[TBL] [Abstract][Full Text] [Related]
25. Nonclassical retinoids and lung carcinogenesis.
Dragnev KH; Petty WJ; Ma Y; Rigas JR; Dmitrovsky E
Clin Lung Cancer; 2005 Jan; 6(4):237-44. PubMed ID: 15694016
[TBL] [Abstract][Full Text] [Related]
26. International Union of Pharmacology. LXIII. Retinoid X receptors.
Germain P; Chambon P; Eichele G; Evans RM; Lazar MA; Leid M; De Lera AR; Lotan R; Mangelsdorf DJ; Gronemeyer H
Pharmacol Rev; 2006 Dec; 58(4):760-72. PubMed ID: 17132853
[TBL] [Abstract][Full Text] [Related]
27. Arginine of retinoic acid receptor beta which coordinates with the carboxyl group of retinoic acid functions independent of the amino acid residues responsible for retinoic acid receptor subtype ligand specificity.
Zhang ZP; Hutcheson JM; Poynton HC; Gabriel JL; Soprano KJ; Soprano DR
Arch Biochem Biophys; 2003 Jan; 409(2):375-84. PubMed ID: 12504905
[TBL] [Abstract][Full Text] [Related]
28. The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention.
Kong G; Kim HT; Wu K; DeNardo D; Hilsenbeck SG; Xu XC; Lamph WW; Bissonnette R; Dannenberg AJ; Brown PH
Cancer Res; 2005 Apr; 65(8):3462-9. PubMed ID: 15833882
[TBL] [Abstract][Full Text] [Related]
29. Retinoid targets in cancer therapy and chemoprevention.
Dragnev KH; Petty WJ; Dmitrovsky E
Cancer Biol Ther; 2003; 2(4 Suppl 1):S150-6. PubMed ID: 14508093
[TBL] [Abstract][Full Text] [Related]
30. Classical and novel retinoids: their targets in cancer therapy.
Fontana JA; Rishi AK
Leukemia; 2002 Apr; 16(4):463-72. PubMed ID: 11960323
[TBL] [Abstract][Full Text] [Related]
31. Early in vitro passages of breast cancer cells are differentially susceptible to retinoids and differentially express RARβ isoforms.
Peng X; Green A; Shilkaitis A; Zhu Y; Bratescu L; Christov K
Int J Oncol; 2011 Sep; 39(3):577-83. PubMed ID: 21667021
[TBL] [Abstract][Full Text] [Related]
32. Natural and synthetic retinoid X receptor ligands and their role in selected nuclear receptor action.
Brtko J; Dvorak Z
Biochimie; 2020 Dec; 179():157-168. PubMed ID: 33011201
[TBL] [Abstract][Full Text] [Related]
33. Retinoids and TRAIL: two cooperating actors to fight against cancer.
Altucci L; Gronemeyer H
Vitam Horm; 2004; 67():319-45. PubMed ID: 15110184
[TBL] [Abstract][Full Text] [Related]
34. Selective retinoids and rexinoids in cancer therapy and chemoprevention.
Zusi FC; Lorenzi MV; Vivat-Hannah V
Drug Discov Today; 2002 Dec; 7(23):1165-74. PubMed ID: 12547017
[TBL] [Abstract][Full Text] [Related]
35. Anticoagulant effects of synthetic retinoids and activated vitamin D3.
Koyama T; Hirosawa S
Semin Thromb Hemost; 1998; 24(3):217-26. PubMed ID: 9701451
[TBL] [Abstract][Full Text] [Related]
36. Retinoic acid receptors and retinoid X receptors in the rat testis during fetal and postnatal development: immunolocalization and implication in the control of the number of gonocytes.
Boulogne B; Levacher C; Durand P; Habert R
Biol Reprod; 1999 Dec; 61(6):1548-57. PubMed ID: 10570002
[TBL] [Abstract][Full Text] [Related]
37. Synthetic retinoids dissociate coactivator binding from corepressor release.
Zechel C
J Recept Signal Transduct Res; 2002; 22(1-4):31-61. PubMed ID: 12503607
[TBL] [Abstract][Full Text] [Related]
38. [Expression of retinoic acid receptors in head and neck squamous cell carcinomas and their possible implication for chemoprevention].
Issing WJ
Laryngorhinootologie; 2001 Sep; 80(9):530-4. PubMed ID: 11555786
[TBL] [Abstract][Full Text] [Related]
39. Suppression of squamous cell carcinoma growth and differentiation by retinoids.
Lotan R
Cancer Res; 1994 Apr; 54(7 Suppl):1987s-1990s. PubMed ID: 8137325
[TBL] [Abstract][Full Text] [Related]
40. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
